For the quarter ending 2026-03-31, ZBIO has $747,682K in assets. $411,853K in debts. $500,224K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 500,224 | 110,641 | 115,565 | 44,006 |
| Short-term investments | 216,981 | 232,551 | 175,319 | 229,273 |
| Prepaid expenses and other current assets | 12,959 | 7,979 | 5,758 | 5,324 |
| Total current assets | 730,164 | 351,171 | 296,642 | 278,603 |
| Property and equipment, net | 28 | 34 | 50 | 61 |
| Operating lease right-of-use assets, net | 1,090 | 1,354 | 807 | 1,010 |
| Long-term investments | 1,340 | 17,272 | 10,717 | 1,614 |
| Other non-current assets | 15,060 | 13,809 | 13,802 | 11,797 |
| Total assets | 747,682 | 383,640 | 322,018 | 293,085 |
| Accounts payable | 8,944 | 7,111 | 6,444 | 7,931 |
| Accrued expenses | 51,180 | 54,423 | 45,359 | 44,520 |
| Operating lease liabilities, current | 1,037 | 1,115 | 618 | 793 |
| Total current liabilities | 61,161 | 62,649 | 52,421 | 53,244 |
| Royalty obligation | 84,900 | - | - | - |
| Senior secured term loan, net | 72,084 | - | - | - |
| Royalty obligation | - | 78,636 | 72,989 | - |
| Convertible senior notes, net | 193,631 | - | - | - |
| Operating lease liabilities, less current portion | 77 | 211 | 180 | 215 |
| Total long-term liabilities | 350,692 | 78,847 | 73,169 | - |
| Total liabilities | 411,853 | 141,496 | 125,590 | 53,459 |
| Common stock, par value 0.0001 per share 175,000,000 shares authorized at march 31, 2026 and december 31, 2025, respectively 62,383,377 and 54,485,518 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 6 | 5 | 4 | 4 |
| Additional paid-in capital | 1,182,315 | 1,007,331 | 721,179 | 712,903 |
| Accumulated other comprehensive loss | -377 | -64 | -69 | -94 |
| Accumulated deficit | -846,115 | -765,128 | -524,686 | -473,187 |
| Total stockholders' equity | 335,829 | 242,144 | 196,428 | 239,626 |
| Total liabilities and stockholders' equity | 747,682 | 383,640 | 322,018 | 293,085 |
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)